Related Experiment Video
Updated: Dec 29, 2025

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting
Published on: December 9, 2022
Role of NKCC1 and KCC2 in Epilepsy: From Expression to Function
Ru Liu1,2,3,4, Junling Wang1,2,3,4, Shuli Liang5
1Neuroelectrophysiological Laboratory, Xuanwu Hospital, Capital Medical University, Beijing, China.
The Na-K-2Cl cotransporter 1 (NKCC1) and K-Cl cotransporter 2 (KCC2) regulate neuronal chloride levels and are implicated in epilepsy. Understanding their function is key to developing new epilepsy treatments.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathophysiology
Background:
- γ-aminobutyric acid (GABA) is a primary inhibitory neurotransmitter in the central nervous system.
- GABAa receptors mediate chloride ion (Cl-) flow, dependent on intracellular chloride concentration ([Cl-]i).
- Cation-chloride cotransporters (CCCs), specifically NKCC1 and KCC2, regulate [Cl-]i by accumulating and extruding Cl-, respectively.
Purpose of the Study:
- To review the expression and function of NKCC1 and KCC2 in epileptogenesis.
- To explore the role of these transporters in the pathophysiology of epilepsy.
- To discuss the potential of NKCC1 and KCC2 as therapeutic targets for epilepsy.
Main Methods:
- Literature review of existing research on NKCC1, KCC2, and epilepsy.
- Analysis of neuroelectrophysiological studies investigating transporter function.
- Synthesis of current understanding of chloride plasticity in epilepsy.
Main Results:
- NKCC1 and KCC2 expression patterns observed in neonatal neurons can reappear in mature neurons during pathophysiological conditions like epilepsy.
- Impaired chloride plasticity, linked to NKCC1 and KCC2 dysfunction, is increasingly associated with epilepsy.
- Further neuroelectrophysiological research is necessary to elucidate the precise mechanisms by which these transporters contribute to epileptogenesis.
Conclusions:
- NKCC1 and KCC2 play a significant role in regulating neuronal chloride homeostasis and are implicated in epilepsy development.
- Targeting NKCC1 and KCC2 offers a promising avenue for the development of novel antiepileptic drugs.
- Continued research into the functional roles of these transporters is crucial for advancing epilepsy treatment strategies.
Related Concept Videos
The Role of Ion Channels in Neuronal Computation
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential....
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

